120 related articles for article (PubMed ID: 10573971)
1. Mechanisms of resistance to fluoroquinolones.
Rattan A
Natl Med J India; 1999; 12(4):162-4. PubMed ID: 10573971
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action and resistance of older and newer fluoroquinolones.
Hooper DC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms for the development of quinolone resistance].
Kojima M
Nihon Rinsho; 1997 May; 55(5):1252-60. PubMed ID: 9155183
[TBL] [Abstract][Full Text] [Related]
4. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.
Schmitz FJ; Higgins PG; Mayer S; Fluit AC; Dalhoff A
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):647-59. PubMed ID: 12373497
[TBL] [Abstract][Full Text] [Related]
5. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of new quinolones against clinical strains of Staphylococcus aureus of the wild type and with mutations characterized by gyrA, gyrB and grlA].
Yagüe Guirao G; Martínez-Toldos MC; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; Martínez-Andrés JA; Muñoz Bellido JL; García-Rodríguez JA; Segovia Hernández M
Rev Esp Quimioter; 2000 Sep; 13(3):271-5. PubMed ID: 11086276
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of bacterial topoisomerases: mechanisms of action and resistance and clinical aspects.
Heisig P
Planta Med; 2001 Feb; 67(1):3-12. PubMed ID: 11270718
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of fluoroquinolones against gram-positive bacteria.
Bush K; Goldschmidt R
Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to quinolones.
Jacoby GA
Clin Infect Dis; 2005 Jul; 41 Suppl 2():S120-6. PubMed ID: 15942878
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
Shen JL; Zhu DM; Wang MG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of quinolone action and microbial response.
Hawkey PM
J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
[TBL] [Abstract][Full Text] [Related]
12. Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.
Yun HJ; Min YH; Jo YW; Shim MJ; Choi EC
Int J Antimicrob Agents; 2005 Apr; 25(4):334-7. PubMed ID: 15784314
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
Ruiz J
J Antimicrob Chemother; 2003 May; 51(5):1109-17. PubMed ID: 12697644
[TBL] [Abstract][Full Text] [Related]
14. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies.
Vickers AA; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of bacterial resistance to quinolones].
Taléns-Visconti R; Garrigues TM; Cantón E
Rev Esp Quimioter; 2002 Mar; 15(1):25-31. PubMed ID: 12582434
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
Chenia HY; Pillay B; Pillay D
J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
[TBL] [Abstract][Full Text] [Related]
17. Quinolone antimicrobial agents: mechanism of action and resistance development.
Bryan LE; Bedard J; Wong S; Chamberland S
Clin Invest Med; 1989 Feb; 12(1):14-9. PubMed ID: 2537696
[TBL] [Abstract][Full Text] [Related]
18. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.
Sierra JM; Cabeza JG; Ruiz Chaler M; Montero T; Hernandez J; Mensa J; Llagostera M; Vila J
Clin Microbiol Infect; 2005 Sep; 11(9):750-8. PubMed ID: 16104991
[TBL] [Abstract][Full Text] [Related]
19. [Role of mutations in parC and gyrA in forming resistance of Mycoplasma hominis to fluoroquinolones].
Gushchin AE; Ladygina VG; Govorun VM
Mol Gen Mikrobiol Virusol; 1999; (4):19-24. PubMed ID: 10621934
[TBL] [Abstract][Full Text] [Related]
20. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
Tao CM; Lü XJ; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
